Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Exploration for Pharmacodynamics and Pharmacokinetic Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects

Trial Profile

The Exploration for Pharmacodynamics and Pharmacokinetic Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs YH 4808 (Primary) ; Amoxicillin; Clarithromycin; Esomeprazole
  • Indications Gastro-oesophageal reflux; NSAID-induced ulcer; Reflux oesophagitis
  • Focus Pharmacokinetics
  • Acronyms YH4808-108
  • Sponsors Yuhan
  • Most Recent Events

    • 31 May 2017 Last checked against Korean Clinical Trials Register
    • 16 Dec 2013 Actual study completion date changed from 1 Nov 2013 to 26 Nov 2013 as reported by Clinical Research Information Service (Cris)- Republic of Korea
    • 16 Dec 2013 Actual initiation date changed from 1 Jul 2013 to 25 Jul 2013 as reported by Clinical Research Information Service (Cris)- Republic of Korea
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top